Giovanna Bergamini

Head of Discovery Biology

Cellzome GmbH, a GSK company

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giovanna Bergamini is the Head of Discovery Biology at Cellzome GmbH, a GSK company, located in Germany. She is engaged in research areas including small molecule inhibitors, pro-fibrotic signaling, and drug target identification, as reflected in her recent publications. Her work encompasses innovative approaches such as multiomic techniques and thermal-shift profiling to enhance drug development strategies.

Articles (5)

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Edith M Hessel

Chief Scientific Officer

Mestag Therapeutics

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanna Bergamini

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Recent progress in small molecule TBK1 inhibitors: a patent review (2015– 2020)

An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in <i>ex vivo</i> human precision-cut lung slices.

Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.

Identifying drug targets in tissues and whole blood with thermal-shift profiling.

Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target.

Collaborators (1)

Edith M Hessel

Make your next move.